Skip to main content
OpenTrials

Clinical trial condition

Mucopolysaccharidosis IV

Explore clinical trials studying Mucopolysaccharidosis IV. Study availability and eligibility vary by location and protocol.

77 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Mucopolysaccharidosis IV trial results

Completed

Clinical Evaluation of Acuity 200 (Fluoroxyfocon A) RGP Contact Lens

NCT03971227

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +21 more
Locations
  • Ala Mona Advanced Eye Clinic Honolulu, Hawaii, United States
  • Cornea and Contact Lens Institute of Minnesota Edina, Minnesota, United States
  • Reed Eye Associates Pittsford, New York, United States
View Trial Details
Completed

Gait Analysis in MPS IVA

NCT01920828

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +11 more
Locations
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details
Completed

BMN 110 Phase 3B in Australian Patients

NCT01966029

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Children's Hospital at Westmead Westmead, New South Wales, Australia
  • Lady Cilento Children's Hospital (previous: Royal Children's Hospital) Brisbane, Queensland, Australia
  • Murdoch Childrens Research Institute and Royal Children's Hospital Melbourne, Victoria, Australia
  • Princess Margaret Hospital for Children Perth, Western Australia, Australia
View Trial Details
Completed

Longitudinal Studies of Brain Structure and Function in MPS Disorders

NCT01870375

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +31 more
Locations
  • Oakland Children's Hospital Oakland, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • New York University New York, United States
  • Hospital for Sick Children Toronto, Ontario, Canada
View Trial Details
Completed

Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children

NCT01111019

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Endocrinologie Pédiatrique - centre des maladies rares de la croissance -Hôpital Necker Enfants Malades Paris, France
View Trial Details

Related conditions